Distributors Expose Health, Life Sci Cos. To FCPA Risks
Health care and life sciences companies with operations in the United States and abroad face increased liability arising from their common reliance on third-party distributors in international markets. Third-party distributors are...To view the full article, register now.
Already a subscriber? Click here to view full article